PROVIDER PROFILE · NPI 1902076821
Andrew Dattila
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
480
Beneficiaries
—
Total drug cost
$771K
Distinct drugs
4
Brand share
94.6%
Top prescribed drugs
Emtricitabine/Tenofov Alafenam371 claims
Emtricitabine/Tenofovir (Tdf)83 claims
Ibuprofen15 claims
Oxycodone Hcl11 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE